Halog: payments to doctors
Payments that named Halog as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $266K
- Providers
- 533
- Transactions
- 1,010
- Average per transaction
- $263
The per-transaction average — $263 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 533 providers the average total is $499, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | $150,095 | 56.5% |
| SUN Pharmaceutical Industries Inc. | $103,724 | 39.0% |
| TARO Pharmaceuticals USA, Inc. | $11,939 | 4.5% |